Even within a JIA cohort started on TNF blockers, patients with ERA were much less likely than those with poly JIA (RF-) to attain inactive disease ever (43 vs. 76%) or be in inactive disease at 1y (24 vs. 57%) (73). Here, TNF is linked to juvenile idiopathic arthritis.